Short selling involves borrowing shares and then selling them at current market prices. In the successful version of the ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

Teleflex Incorporated TFX posted fourth-quarter 2024 adjusted earnings per share (EPS) from continuing operations of $3.89, ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Raymond James downgraded Teleflex (TFX) to Market Perform from Outperform without a price target The firm likes the company’s active portfolio ...

Principal Financial Group Inc. reduced its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 13.1% during the fourth ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Teleflex vascular access (24% of sales) is a no-moat business, in our view. While Teleflex leads the market for central venous catheters, or CVC, tubes that are connected to veins and used to deliver ...

Technology shares were the leading losers among S&P 500 sectors as solid earnings reported by Nvidia late Wednesday were offset by President Trump's confirmation that 25% tariffs on Mexico and Canada ...

Teleflex Inc. closed 44.33% below its 52-week high of $249.91, which the company reached on September 27th.

Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company reported ...